PHG News and Press, Koninklijke Philips N.V. NY Registry Shares From 04/25/22

Philips (NYSE:PHG) ADRs have lost ~13% in the pre-market on Monday after the Dutch health equipment company reported ~4% decline in its comparable sales for 1Q 2022 amid supply issues and an ongoing recall of its certain respiratory care devices. While the group sales for the q...

Philips press release (NYSE:PHG): Q1 Non-GAAP EPS of €0.15. Revenue of €3.92B (+2.3% Y/Y) 4% Comparable sales decline 4% on the back of 9% comparable sales growth in Q1 2021. Comparable order intake increased 5%, driven by the Diagnosis & Treatment businesses and H...

April 25, 2022 First-quarter highlights Group sales amounted to EUR 3.9 billion, with a 4% comparable sales decline on the back of 9% comparable sales growth in Q1 2021 Comparable order intake increased 5%, driven by the Diagnosis & Treatment businesses and Hospital ...

Dutch healthcare equipment maker, Royal Philips (NYSE:PHG) announced on Friday that its subsidiary Philips Respironics has issued a recall notification for the U.S. and a field safety notice for the rest of the world regarding its V60/V60 Plus and V680 ventilators. The company has made the de...

April 22, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its subsidiary Philips Respironics is notifying customers of its V60/V60 Plus and V680 ventilators about a potential issue wi...

Philips is transforming from an electronics to a health-tech company. During the transformation, the company managed debt levels well and maintained shareholder returns. The risk profile of the company, however, has deteriorated as the diversification reduced by solely focusing on...

Royal Philips (NYSE:PHG) said the first patients were successfully treated for Inferior Vena Cava (IVC) filter removal using its IVC Filter Removal Laser Sheath, CavaClear. The company said IVC filters are used to treat patients with venous thromboembolism, blood clots in veins of the leg and...

April 21, 2022 First use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter Only FDA-cleared solution for advanced IVC filter removal safely ablates tissue and removes e...

We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by managers who think and act as owne...

April 11, 2022 Strategic 10-year agreement will support large-scale transformation of Oulu University Hospital and their aim to become ‘the smartest hospital in the world’ Philips’ latest diagnostic and interventional solutions and healthcare transfo...